Clinical Trials Browser

Phase 1/2 × Has results × darolutamide × Clear all

NCT04737109 2023-11-13

ADDItion

Phase 1/2 Terminated

6 enrolled 9 charts

Prostatic Neoplasms

NCT01317641 2017-03-29

Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer

Phase 1/2 Completed

136 enrolled 28 charts

Prostatic Neoplasms